Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON34891
NL-OMON34891
Completed
Not Applicable

Clinical validation of the dried blood spot analysis for antituberculosis drugs - DBS analysis of anti-TB drugs

niversitair Medisch Centrum Groningen0 sites33 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsBlood concentration of anti TB drugs10028440

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Blood concentration of anti TB drugs
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
33
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •\- Adult (\>18 years old)
  • •\- TB\-patient who using at least one of the following drugs: Isoniazid, Pyrazinamide, Rifampicin, Ethambutol, clarithromycin, Amikacin, Kanamycin, Moxifloxacin, Linezolid
  • •\- TB\-patient who is scheduled for routine TDM by the doctor.
  • •\- written informed consent

Exclusion Criteria

  • •Patients with serious bleeding disorder

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528
NL-OMON44369Afdeling Apotheek89
Withdrawn
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study).analysis of drugs used for tuberculosis10004018
NL-OMON42070niversitair Medisch Centrum Sint Radboud10
Recruiting
Not Applicable
Validation of dried blood spot sampling in therapeutic drug monitoring of cyclosporiTransplantation of hematopoetic stem cells or kidney10003816
NL-OMON34000Vrije Universiteit Medisch Centrum40
Completed
Not Applicable
Validation of dried blood spot sampling in therapeutic drug monitoring of nilotinibChronic Myelogenous LeukemiaCancer of white blood cells10024324
NL-OMON37855Vrije Universiteit Medisch Centrum40
Completed
Not Applicable
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesnvt10013511
NL-OMON45799Erasmus MC, Universitair Medisch Centrum Rotterdam120